Related references
Note: Only part of the references are listed.COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Raches Ella et al.
LANCET INFECTIOUS DISEASES (2021)
Chemokines and chemokine receptors during COVID-19 infection
Bariaa A. Khalil et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
Raches Ella et al.
LANCET INFECTIOUS DISEASES (2021)
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
Pragya D. Yadav et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis et al.
NPJ VACCINES (2021)
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation
Brunda Ganneru et al.
ISCIENCE (2021)
Heterologous vaccine interventions: boosting immunity against future pandemics
Daniela Marin-Hernandez et al.
MOLECULAR MEDICINE (2021)
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection
Natalia Sherina et al.
MED (2021)
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Mihai G. Netea et al.
CELL (2020)
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Victor J. Costela-Ruiz et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment
Branko Cirovic et al.
CELL HOST & MICROBE (2020)
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
Evangelos J. Giamarellos-Bourboulis et al.
CELL (2020)
Vaccines for COVID-19
J. S. Tregoning et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Fang Gong et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Defining trained immunity and its role in health and disease
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses
Petra Zimmermann et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
The Role of Interleukin 6 During Viral Infections
Lauro Velazquez-Salinas et al.
FRONTIERS IN MICROBIOLOGY (2019)
Maternal BCG scar is associated with increased infant proinflammatory immune responses
Patrice Akusa Mawa et al.
VACCINE (2017)
Cytokines and persistent viral infections
Jean-Christophe Beltra et al.
CYTOKINE (2016)
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
Nikolai Petrovsky
DRUG SAFETY (2015)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways
Victoria J. Philbin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
Nikunj M. Shukla et al.
PLOS ONE (2012)
Modulation of chemokine activity by viruses
Antonio Alcami et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors
Anja Moldenhauer et al.
BMC IMMUNOLOGY (2008)
Chemokines: Key players in innate and adaptive immunity
C Esche et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function
J Melchjorsen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Viral mimicry of cytokines, chemokines and their receptors
A Alcami
NATURE REVIEWS IMMUNOLOGY (2003)
IL-7 enhances the survival and maintains the size of naive T cells
JC Rathmell et al.
JOURNAL OF IMMUNOLOGY (2001)
Molecular pathways in virus-induced cytokine production
TH Mogensen et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)